Published in J R Soc Med on January 01, 2014
Autophagy and neurodegeneration. J Clin Invest (2015) 1.24
Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies. Brain (2014) 0.83
Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener (2016) 0.82
Importance of sample size for the estimation of repeater F waves in amyotrophic lateral sclerosis. Chin Med J (Engl) (2015) 0.82
Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies. PLoS One (2014) 0.78
Smads as muscle biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol (2014) 0.78
Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol Commun (2015) 0.77
Amyotrophic lateral sclerosis and environmental factors. Funct Neurol (2016) 0.77
Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.76
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study. Eur J Hum Genet (2017) 0.75
Changes in the Expression of FUS/TLS in Spinal Cords of SOD1 G93A Transgenic Mice and Correlation with Motor-Neuron Degeneration. Int J Biol Sci (2016) 0.75
Rare diseases: matching wheelchair users with rare metabolic, neuromuscular or neurological disorders to electric powered indoor/outdoor wheelchairs (EPIOCs). Disabil Rehabil (2015) 0.75
A three-groups model for high-throughput survival screens. Biometrics (2016) 0.75
Puzzles in modern biology. IV. Neurodegeneration, localized origin and widespread decay. F1000Res (2016) 0.75
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science (2013) 6.34
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci (2011) 6.01
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol (2011) 2.55
ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology (2009) 2.47
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry (2011) 2.45
Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology (2010) 2.05
The seeds of neurodegeneration: prion-like spreading in ALS. Cell (2011) 2.03
Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol (2009) 1.99
How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol (2012) 1.81
The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta (2006) 1.72
Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol (2011) 1.59
The role of RNA processing in the pathogenesis of motor neuron degeneration. Expert Rev Mol Med (2010) 1.36
Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology (2013) 1.31
Neuroimaging in amyotrophic lateral sclerosis. Biomark Med (2012) 1.23
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler (2012) 1.18
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review. Arch Neurol (2012) 1.13
A proposed staging system for amyotrophic lateral sclerosis. Brain (2012) 1.08
Mimics and chameleons in motor neurone disease. Pract Neurol (2013) 1.07
Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol (2012) 1.05
Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology (2012) 1.00
Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth? J Neurol Neurosurg Psychiatry (2013) 0.87
Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level? Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.85
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet (2007) 3.09
Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet (2004) 3.00
Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet (2004) 2.86
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol (2008) 2.76
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial. Lancet Neurol (2015) 2.51
Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology (2013) 2.18
Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry (2009) 2.14
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet (2010) 1.96
Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain (2013) 1.95
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.93
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage (2011) 1.88
Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet (2009) 1.76
Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry (2011) 1.67
Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol (2006) 1.61
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain (2011) 1.57
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet (2008) 1.46
What is the place of thrombolysis in acute stroke? A review of the literature and a current perspective. Clin Med (2008) 1.42
Motor neurone disease is a clinical diagnosis. Pract Neurol (2012) 1.40
Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study. J Neurol Neurosurg Psychiatry (2011) 1.40
GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci (2010) 1.40
The role of RNA processing in the pathogenesis of motor neuron degeneration. Expert Rev Mol Med (2010) 1.36
Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet (2011) 1.32
Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology (2013) 1.31
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Hum Mol Genet (2010) 1.30
The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci (2010) 1.30
Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet (2009) 1.26
Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet (2011) 1.25
Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes (2011) 1.23
An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech (2009) 1.22
A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet (2005) 1.21
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat (2012) 1.15
Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol (2011) 1.15
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis Model Mech (2011) 1.15
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum Mutat (2011) 1.14
Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp (2009) 1.11
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry (2011) 1.10
A proposed staging system for amyotrophic lateral sclerosis. Brain (2012) 1.08
Mimics and chameleons in motor neurone disease. Pract Neurol (2013) 1.07
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol (2011) 1.07
Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol (2012) 1.04
REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease. J Neurol Neurosurg Psychiatry (2013) 1.03
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol Dis (2009) 1.02
Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler (2010) 1.02
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett (2007) 1.00
The molecular genetics of non-ALS motor neuron diseases. Biochim Biophys Acta (2006) 1.00
Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.00
Functional vitamin B12 deficiency. Pract Neurol (2009) 0.99
Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease. Hum Brain Mapp (2013) 0.98
Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain (2007) 0.98
Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Mov Disord (2014) 0.98
Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology (2008) 0.98
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis. Muscle Nerve (2013) 0.97
Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol (2014) 0.94
The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler (2010) 0.94
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum Mol Genet (2013) 0.93
Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS. J Neurol Sci (2009) 0.93
Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum Mol Genet (2013) 0.92
Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006. J Neurol (2009) 0.92
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathol Commun (2014) 0.91
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol (2013) 0.91
Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.90
Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). Health Qual Life Outcomes (2011) 0.90
Normal d-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis. J Neurol (2002) 0.90
TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy. BMC Neurosci (2008) 0.90
The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.89
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis. Arch Neurol (2009) 0.89
Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Hum Mol Genet (2009) 0.88
Public awareness of motor neuron disease. Amyotroph Lateral Scler (2010) 0.87
SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe. Orphanet J Rare Dis (2013) 0.87
Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth? J Neurol Neurosurg Psychiatry (2013) 0.87
Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level? Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.85
Novel SPG11 mutations in Asian kindreds and disruption of spatacsin function in the zebrafish. Neurogenetics (2010) 0.85
Some difficult decisions in ALS/MND. Amyotroph Lateral Scler (2010) 0.85
The borderland of neuromyelitis optica. Pract Neurol (2009) 0.84
Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy. J Neurol (2013) 0.83
A case of celiac disease mimicking amyotrophic lateral sclerosis. Nat Clin Pract Neurol (2007) 0.83
The internet for self-diagnosis and prognostication in ALS. Amyotroph Lateral Scler (2010) 0.82
Murray Valley encephalitis in an adult traveller complicated by long-term flaccid paralysis: case report and review of the literature. Trans R Soc Trop Med Hyg (2006) 0.82
Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.82
HspB8 mutation causing hereditary distal motor neuropathy impairs lysosomal delivery of autophagosomes. J Neurochem (2011) 0.81
The association between ALS and population density: A population based study. Amyotroph Lateral Scler (2010) 0.81
Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 0.80
Primary angiitis of the CNS mimicking a spinal cord tumour. J Neurol (2009) 0.80
A novel central motor conduction abnormality in D90A-homozygous patients with amyotrophic lateral sclerosis. Muscle Nerve (2004) 0.80
Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 0.79
MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers? Biomark Med (2011) 0.79
When to consider thyroid dysfunction in the neurology clinic. Pract Neurol (2009) 0.79
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study. Amyotroph Lateral Scler (2008) 0.79